Results 21 to 30 of about 3,498 (121)

Surgical management of pancreatico-duodenal tumors in multiple endocrine neoplasia syndrome type 1

Clinics, 2012
Pancreatico-duodenal tumors are the second most common endocrinopathy in multiple endocrine neoplasia syndrome type 1, and have a pronounced effect on life expectancy as the principal cause of disease-related death.
Göran Åkerström, Peter Stålberg, Per Hellman   +2 more
doaj   +1 more source

Zollinger-Ellison syndrome associated with neurofibromatosis type 1: a case report

BMC Cancer, 2005
Background Neurofibromatosis type 1 is an autosomal dominant neurocutaneous disorder with characteristic features of skin and central nervous system involvement. Gastrointestinal involvement is rare, but the risk of malignancy development is considerable.
Choi Sung-Kyu, Cho Chol-Kyoon, Kim Hyun-Soo, Joo Young-Eun, Park Chang-Hwan, Kim Jung-Chul, Koh Yang-Seok, Lee Wan-Sik, Rew Jong-Sun, Kim Sei-Jong   +9 more
doaj   +1 more source

A rare case of a metastatic neuroendocrine tumor of the pancreas

Бюллетень сибирской медицины, 2021
Aim. To study a rare sporadic case of metastatic gastrinoma associated with mutations in the MEN1 and TSC2 genes in a 25-year-old male.Materials and methods. A retrospective analysis of the history of a 25-year-old patient with sporadic gastrinoma with a
O. I. Kit, V. S. Trifanov, N. N. Timoshkina, E. N. Kolesnikov, D. Y. Gvaldin, N. S. Karnaukhov, D. S. Kutilin, M. Y. Meshcheryakova   +7 more
doaj   +1 more source

Oral Pantoprazole for Acid Suppression in the Treatment of Patients with Zollinger-Ellison Syndrome

Canadian Journal of Gastroenterology, 2001
BACKGROUND: The management of patients with gastric acid hypersecretion due to gastrinoma, usually recognized as Zollinger-Ellison syndrome (ZES), was radically changed 10 years ago by the use of proton pump inhibitors.
Barbara Désir, Pierre Poitras
doaj   +1 more source

Massive gastrointestinal bleed due to multiple gastric neuroendocrine tumors

Journal of Digestive Endoscopy, 2015
Gastric neuroendocrine tumors (G-NETs) are uncommon lesions which are usually diagnosed on histological evaluation of gastric polyps. These may occur sporadically or due to hypergastrinemia in the setting of atrophic gastritis or Zollinger-Ellison ...
Vishal Sharma, Surinder Singh Rana, Paramvir Singh Mangat, Lileswar Kaman, Deepak Kumar Bhasin   +4 more
doaj   +1 more source

Bringing SASI back: Single session selective arterial secretin injection and transarterial embolization of intrahepatic pancreatic neuroendocrine metastasis in a MEN-1 patient

Radiology Case Reports, 2018
SASI (selective arterial secretin injection) is a form of ASVS (arterial stimulation and venous sampling) used to localize pancreatic gastrinomas. This report aims to review the protocol for SASI and demonstrate its utility in localizing functional and ...
Jawad S. Hussain, MD, MS, Ravi N. Srinivasa, MD, Anthony Hage, BS, Rudra Pampati, MD, Jeffrey Forris Beecham Chick, MD, MPH, DABR   +4 more
doaj   +1 more source

Sporadic duodenal macrogastrinoma: a rare case report

Acta Medica Lituanica, 2013
Gastrinomas are rare neuroendocrine tumors characterized by the secretion of gastrin, which causes hyperchlorhydria, thereby producing the Zollinger-Ellison syndrome. In most cases this syndrome manifests as severe peptic ulcer disease. We are presenting
Dainius Šimčikas, Eligijus Poškus, Juozas Stanaitis, Ernesta Rinkevičiūtė, Algirdas Edvardas Tamošiūnas, Kęstutis Strupas   +5 more
doaj   +1 more source

Primary hepatic gastrinoma being diagnosed preoperatively: a case report and literature review

Surgical Case Reports, 2020
Background A majority of gastrinomas causing Zollinger–Ellison syndrome are located in the duodenum or pancreas. Primary hepatic gastrinomas are rare and difficult to diagnose. We report a rare case of primary hepatic gastrinoma, which could be diagnosed
Shunya Hanzawa, Hiroshi Sadamori, Masaaki Kagoura, Kazuteru Monden, Masayoshi Hioki, Tsuyoshi Hyodo, Kunihiro Omonishi, Norihisa Takakura   +7 more
doaj   +1 more source

Current Potential of Pantoprazole in Treatment and Prevention of Gastrointestinal Diseases

Российский журнал гастроэнтерологии, гепатологии, колопроктологии, 2021
Aim. An outline of the current potential of pantoprazole in treatment and prevention of upper gastrointestinal diseases.Key points. Pantoprazole is widely applied in gastroesophageal reflux, peptic ulcer disease, Zollinger—Ellison syndrome and for ...
A. A. Sheptulin, S. S. Kardasheva, A. A. Kurbatova   +2 more
doaj   +1 more source

The TOP‐GERD Trial: Comparative Efficacy of Tegoprazan Versus Pantoprazole in the Treatment of Erosive Oesophagitis in a Non‐Asian Population

Alimentary Pharmacology &Therapeutics, EarlyView.
In this randomized, double‐blind trial in Mexican adults with erosive oesophagitis, tegoprazan did not significantly improve the primary 4‐week ITT healing endpoint versus pantoprazole (88.9% vs. 79.4%; p = 0.33), but produced faster symptom improvement. Encouraging per‐protocol and severe‐oesophagitis findings warrant confirmation.
José M. Remes‐Troche, Luis Raúl Valdovinos‐García, C. Prakash Gyawali, José Luis Vargas‐Basurto, Carlos Alberto Reyes‐Medina, Gisselle Vanessa González‐Hernández, A. Rafael Bernal Mendez, H. H. Barragán Cordova, Pablo Thomas‐Dupont, Peter Grube‐Pagola   +9 more
wiley   +1 more source